Saturday, May 18, 2024 | Last Update : 11:20 PM IST

Venetoclax

Drug to ‘melt’ cancer cells in chronic cases

Venetoclax has been approved for some stage-four patients of chronic lymphocytic leukaemia, say scientists.

11 Jan 2017 5:13 AM

ADVERTISEMENT
ADVERTISEMENT